EUCTR2015-004391-29-ES进行中（未招募）1 期
Effectiveness of intragastric injection of botulinum toxin by endoscopy in obese patients in surgical waiting list. Study InBoTox - InBoTox
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)0 个研究点目标入组 60 人开始时间: 2016年2月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Male or female
- •2. Age 18-65 years
- •3. BMI> 40 or BMI> 35 with comorbidities
- •4. Waiting list for bariatric surgery between 6 and 12 months before the intervention.
- •5. Willingness to attend scheduled visits
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 60
排除标准
- •1. Obesity of endocrine origin.
- •2. Recent anti-obesity 2 treatment (<3 months).
- •3. myopathy, known neuromuscular or neurological disease
- •4. Severe Psychopathology contraindicating procedure
- •5. active gastrointestinal disease (esophagitis, peptic ulcer, cancer, etc., already diagnosed).
- •6. History of gastric surgery.
- •7. previous botulism.
- •8. dysfunction of gastrointestinal motility because of opioids, anticholinergics or other drugs.
- •9. known intolerance upper endoscopy.
- •10. Pregnant or breast-feeding.
研究者
相似试验
已完成
不适用
Intragastric injection of botulinum toxin A for the treatment of obesityobesityJPRN-UMIN000020931Juntendo University Hospital Department of Gastroenterology30
进行中（未招募）
1 期
Intragastrale Injektion von Botulinum Toxin A zur Behandlung der AdipositasDie morbide Adipositas nimmt in westlichen Ländern stetig zu. In Österreich und Deutschland sind ca. 30% der Erwachsenen übergewichtig und 1% (900.000 Erwachsene) morbid adipös. In den USA stellt die Adiposita ein schwerwiegendes gesundheitliches Problem dar. Geschätzte 60% der Amerikaner sind übergewichtig und über 6% (12 Millionen) morbid adipös.EUCTR2005-001095-13-ATMedical University Innsbruck20
招募中
3 期
The effect of botulinum in obese patientsIRCT20230408057842N2Shahid Beheshti University of Medical Sciences60
已完成
2 期
The effect of injection of Botulinum toxin A on Benign Prostatic HyperplasiaBenign Prostatic Hyperplasia.Hyperplasia of prostateIRCT201008174582N1Vice chancellor for research of Guilan University of Medical Sciences10
尚未招募
不适用
Effectiveness of Botulinum Toxin Infiltration for treatment of upper limb dysfunctions after treatment for breast cancer.Patients treated for breast cancer and chronic pain (> 3 months) at the breast regionNL-OMON26807Z Leuven50